Radionetics Oncology
Jonathan Ableson is an accomplished professional with extensive experience in executive support and business operations across various sectors, including healthcare and oncology. Currently serving as an Associate in Business Operations at Radionetics Oncology since December 2021, Jonathan previously worked as an Executive Assistant at DNAtrix, where responsibilities included supporting senior executives, coordinating meetings, managing corporate data rooms, and assisting with recruitment processes. Prior experience includes roles at HUYA Bioscience International, Anti-Defamation League, MDDN, Cranberry Road Management, and NHS, demonstrating a strong background in administrative support, meeting management, and clinical study documentation. Jonathan holds a Professional Certificate in Clinical Trials Design & Management from UC San Diego.
This person is not in the org chart
Radionetics Oncology
Radionetics Oncology is a pharmaceutical company focused on the discovery and development of novel radiotherapeutics for the treatment of a wide range of oncology indications. The company’s platform technology uses nonpeptide, small molecule targeting to deliver therapeutic radioisotopes to a broad range of cancers by binding selectively to peptide receptors that are selectively expressed on these tumors. This nonpeptide technology addresses many of the significant challenges currently facing peptide and protein targeted radiotherapeutics, particularly in the realm of optimizing drug-like characteristics and manufacturing. The company is rapidly advancing a pipeline of drug candidates to treat a broad range of cancers and is conducting additional drug discovery efforts to identify drug candidates for additional receptor targets in collaboration with Crinetics Pharmaceuticals.